Clinical Trial Update: Atherosclerosis Monitoring and Atherogenicity Reduction Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a study on monitoring carotid atherosclerosis and reducing atherogenicity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Atherosclerosis

Snippet

Sponsor: Institute for Atherosclerosis Research, Russia | Conditions: Carotid Atherosclerosis | Phase 3 | Status: COMPLETED